Bath & Body Works (NYSE:BBWI) Stock Price Expected to Rise, Piper Sandler Analyst Says

Bath & Body Works (NYSE:BBWI) had its price objective upped by equities research analysts at Piper Sandler from $35.00 to $36.00 in a research report issued on Tuesday,Benzinga reports. The firm presently has a “neutral” rating on the stock. Piper Sandler’s price target indicates a potential upside of 0.61% from the stock’s current price.

BBWI has been the topic of a number of other reports. BMO Capital Markets reissued an “outperform” rating and set a $50.00 price target (down from $52.00) on shares of Bath & Body Works in a research report on Thursday, August 29th. Citigroup decreased their target price on Bath & Body Works from $48.00 to $35.00 and set a “neutral” rating for the company in a research note on Tuesday, August 20th. Morgan Stanley lowered their price target on Bath & Body Works from $51.00 to $48.00 and set an “overweight” rating for the company in a report on Thursday, November 21st. UBS Group cut their price objective on Bath & Body Works from $52.00 to $38.00 and set a “neutral” rating on the stock in a report on Thursday, August 29th. Finally, Robert W. Baird lowered their target price on Bath & Body Works from $54.00 to $45.00 and set an “outperform” rating for the company in a research note on Thursday, August 29th. One analyst has rated the stock with a sell rating, six have issued a hold rating and nine have given a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $42.06.

Bath & Body Works Trading Up 16.5 %

NYSE BBWI opened at $35.78 on Tuesday. Bath & Body Works has a 12 month low of $26.20 and a 12 month high of $52.99. The stock has a 50-day simple moving average of $30.69 and a 200 day simple moving average of $35.74. The company has a market capitalization of $7.84 billion, a PE ratio of 8.66, a P/E/G ratio of 0.98 and a beta of 1.79.

Bath & Body Works (NYSE:BBWI) last announced its quarterly earnings results on Wednesday, August 28th. The company reported $0.37 EPS for the quarter, beating analysts’ consensus estimates of $0.35 by $0.02. Bath & Body Works had a negative return on equity of 41.94% and a net margin of 12.69%. The company had revenue of $1.53 billion during the quarter, compared to analysts’ expectations of $1.54 billion. As a group, sell-side analysts predict that Bath & Body Works will post 3.18 earnings per share for the current fiscal year.

Insiders Place Their Bets

In related news, CEO Gina Boswell purchased 6,000 shares of the stock in a transaction on Wednesday, October 9th. The shares were purchased at an average cost of $29.64 per share, with a total value of $177,840.00. Following the acquisition, the chief executive officer now directly owns 242,987 shares in the company, valued at $7,202,134.68. The trade was a 2.53 % increase in their ownership of the stock. The acquisition was disclosed in a document filed with the SEC, which is accessible through this link. Insiders own 0.27% of the company’s stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. First Community Trust NA bought a new stake in shares of Bath & Body Works during the 2nd quarter worth approximately $30,000. True Wealth Design LLC boosted its holdings in shares of Bath & Body Works by 5,270.0% during the 3rd quarter. True Wealth Design LLC now owns 1,074 shares of the company’s stock valued at $34,000 after acquiring an additional 1,054 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt grew its holdings in shares of Bath & Body Works by 300.0% during the third quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 1,200 shares of the company’s stock worth $38,000 after purchasing an additional 900 shares during the last quarter. Wilmington Savings Fund Society FSB acquired a new position in Bath & Body Works in the 3rd quarter valued at approximately $39,000. Finally, TD Private Client Wealth LLC increased its holdings in Bath & Body Works by 24.2% in the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company’s stock valued at $54,000 after purchasing an additional 331 shares during the period. Institutional investors and hedge funds own 95.14% of the company’s stock.

About Bath & Body Works

Bath & Body Works, Inc operates a specialty retailer of home fragrance, body care, and soaps and sanitizer products. It sells its products under the Bath & Body Works, White Barn, and other brand names through retail stores and e-commerce sites located in the United States and Canada, as well as through international stores operated by partners under franchise, license, and wholesale arrangements.